TREACE MEDICAL CONCEPTS, INC.

TREACE MEDICAL CONCEPTS, INC. specializes in the design, manufacture, and supply of advanced orthopedic surgical implants and instruments, with a focused expertise in minimally invasive bunion correction systems. The company’s core capabilities center on the development of proprietary surgical implant platforms, including speed plates, compression implants, and arthrodesis systems, specifically engineered for first metatarsophalangeal joint reconstruction. Their technical proficiency lies in biomechanically optimized metallic implant design, precision surgical instrumentation, and FDA-regulated manufacturing processes compliant with ISO 13485 standards. A key differentiator is their innovation in LAPIPLASTY® technology, a patented three-dimensional correction system that addresses metatarsal malalignment at its source, distinguishing them in the podiatric surgical market. The contractor maintains a dominant relationship with the Department of Veterans Affairs, consistently delivering orthopedic implants and surgical supplies to VA medical centers for lower extremity reconstruction. These procurements support veteran-specific musculoskeletal care pathways, particularly for post-traumatic and degenerative foot conditions. The Department of Defense is also a minor customer, indicating potential alignment with military medical readiness and trauma care needs. TREACE operates primarily under NAICS 339113 (Surgical Appliance and Supplies Manufacturing) and 339112 (Surgical and Medical Instrument Manufacturing), positioning them squarely within the orthopedic implant and surgical device sector. Their market focus is on specialty surgical solutions for foot and ankle reconstruction, serving a niche but high-growth segment of the broader medical device industry. As a privately held entity headquartered in Ponte Vedra, Florida, TREACE MEDICAL CONCEPTS, INC. is structured as a small business with no federal certifications on record. The company’s geographic presence is centered in Florida, with its commercial and manufacturing operations tailored to meet federal healthcare procurement requirements through direct supply chains and regulated medical device distribution protocols.